plasma therapy

Stephen A. Smith’s strong denial of criticism surrounding Luka Doncic sparked further debate after his on-air comments appeared to question the legitimacy of the Lakers star’s injury. With video evidence circulating and a confirmed Grade 2 hamstring strain, the focus shifted from opinion to accountability. Meanwhile, Doncic is prioritizing recovery, planning a trip to Europe for advanced treatment options. As the playoffs approach, his health has become central to the Lakers’ hopes, making both the controversy and the injury impossible to ignore.

The capital has received the Centre's approval for starting the third phase of plasma therapy trials, under which 200 patients would undergo the procedure.

A private hospital in Madhya Pradesh's Indore city has started plasma therapy trials on three coronavirus patients, who are in serious condition, an official said on Monday. Two doctors, who recovered from Covid-19 after treatment, came forward to donate their plasma (a component of blood) for these patients, Sri Aurobindo Institute of Medical Sciences (SAIMS) chest disease department head Dr Ravi Dosi told

CM Pramod Sawant on Wednesday said that plasma therapy for critically ill Covid patients will start next week.

The Indian Council of Medical Research (ICMR) issued a big statement on Tuesday regarding plasma therapy, which is touted as a life saving intervention for patients suffering from severe Covid-19.

District collector Daulat Desai on Friday said the first attempt of treating a Covid-19 patient using plasma therapy in Kolhapur’s Chhatrapati Pramilaraje (CPR) hospital has been successful.

It will be sometime before Kerala starts the convalescent plasma therapy as a treatment option for Covid-19.

Uttar Pradesh joined Delhi to start plasma therapy to treat critical coronavirus patients in the country. King George’s Medical University (KGMU) collected the plasma of two donors on Saturday and became the first medical institute in the state to began the therapy to treat serious patients with matching blood group across the state.

Convalescent plasma therapy reportedly showing positive results on Covid-19 patients in a Delhi hospital has prompted medical institutions in Karnataka to try the same as a treatment in their hospitals.

A 47-year-old woman has recovered from Covid-19 after undergoing convalescent plasma therapy at Sassoon hospital. This is the city’s first successful plasma therapy recovery.

Promising outcomes of plasma therapy – the only glimmer of hope against Covid-19 -- have come to fore in Uttar Pradesh.

Initial findings from the trials at AIIMS to assess the efficacy of convalescent plasma therapy for Covid-19 patients have arrived. It shows that the therapy does not reduce the risk of death due to the infection by the novel coronavirus.

The civic-run BYL Nair Hospital, that was the foremost institute from the city to participate in the Indian Council of Medical Research’s (ICMR) plasma trial,

Three out of 13 districts in Andhra Pradesh have not performed or did not need to undertake plasma therapy as treatment for Covid-19. The districts— Vizianagaram, Chittoor and West Godavari—have Covid-19 positivity rates and mortality rates below the state average.

The clinical trial in convalescent plasma therapy for treatment of critically ill Covid-19 patients will begin on Saturday, medical education minister K Sudhakar said on Friday. Bengaluru-based cancer hospital, HCG, in association with Bangalore Medical College and Research Institute was given the approval by the Drug Controller General of India for conducting clinical trials of convalescent plasma therapy three days ago. Plasma is the almost clear liquid part of the blood.

The health ministry on Tuesday came out with an emphatic warning that it has not approved plasma therapy for the treatment of coronavirus and this should be used only for research and trial purposes for now. The announcement came as a surprise as some private hospitals have used plasma or immune therapy on patients needing enhanced respiratory support.

In an observation, Nagpur bench of Bombay high court quoted scientists to state that convalescent plasma therapy is possibly leading to new Covid-19 viral strains and thus fuelling the pandemic.

Bikaner and Ajmer medical colleges have written to the Drugs Controller General of India (DCGI) seeking permission to conduct plasma therapy on needy Covid patients.

A private hospital in Bengaluru has been given the nod by Indian Council of Medical Research to conduct clinical trials on COVID-19 patients using plasma therapy. The Minister for Medical Education, Dr K Sudhakar said plasma therapy holds great promise in treating Covid-19 patients and permission has been given for plasma treatment to HCG Bangalore Inst of Oncology.

Doctors believe that while there may be a certain subset of Covid patients who may benefit from plasma therapy, it is still a work in progress

The health ministry on Tuesday said currently plasma therapy is at experimental stage and there is no evidence yet to support that it can be used as treatment for Covid-19. The ministry said currently there are no approved therapies for Covid-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.

Rajasthan has become the fourth state in the country to start treating Covid-19 patients with plasma therapy. The first two Covid-19 patients, who were given plasma therapy at Sawai Man Singh (SMS) Hospital, has shown signs of improvement.

Doctors at the state-run Rajendra Institute of Medical Sciences (Rims) plan to start plasma therapy for seriously ill Covid-19 patients on an experimental basis after the treatment showed promise in curing many patients across the globe and in the country. Currently, Jharkhand has no critically ill Covid-19 patient.

Blood plasma therapy that is being touted as the final resort to treat Covid-19 has not convinced the US Food and Drug Administration (FDA) as it has put the emergency use authorisation for blood plasma to treat the deadly respiratory disease on hold, the media reported.

The Indian Council of Medical Research (ICMR) has given its nod to Rajasthan's appeal for using convalescent plasma therapy in treating COVID-19 patients, Chief Minister Ashok Gehlot said on Sunday.

Rajasthan is prepared to conduct plasma therapy on severely-ill COVID-19 patients and has written to the Indian Council of Medical Research (ICMR) seeking permission to carry out the treatment, state health minister Raghu Sharma said on Saturday.

Though Bengaluru-based HCG Cancer Centre obtained approval from the Drug Controller General of India (DCGI) to start clinical trials of convalescent plasma therapy on critically ill Covid-19 patients, two units of plasma donated by two persons remain unused. Reason: None of the seven patients in ICUs across the state is eligible to get plasma under the therapy protocol.